Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,078 | 199 | 97.9% |
| Education | $64.54 | 2 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $571.66 | 31 | $0 (2024) |
| ABBVIE INC. | $488.99 | 39 | $0 (2024) |
| Amgen Inc. | $333.25 | 19 | $0 (2024) |
| PFIZER INC. | $230.66 | 14 | $0 (2024) |
| Amarin Pharma Inc. | $226.58 | 16 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $165.14 | 12 | $0 (2024) |
| GlaxoSmithKline, LLC. | $157.31 | 10 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $104.77 | 6 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $75.58 | 5 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $75.11 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $913.52 | 50 | Novo Nordisk Inc ($297.38) |
| 2023 | $731.49 | 49 | Novo Nordisk Inc ($181.07) |
| 2022 | $771.90 | 53 | Amgen Inc. ($167.31) |
| 2021 | $519.68 | 34 | Amarin Pharma Inc. ($114.58) |
| 2020 | $205.81 | 15 | Amarin Pharma Inc. ($112.00) |
All Payment Transactions
201 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: RESPIRATORY | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Gastroenterology | ||||||
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Gastroenterology | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.71 | General |
| 10/22/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/22/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Diabetes Care | ||||||
| 10/11/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: VACCINES | ||||||
| 10/07/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: RESPIRATORY | ||||||
| 10/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Inflammation | ||||||
| 10/03/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $33.37 | General |
| Category: Obesity | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Oncology | ||||||
| 09/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Gastroenterology | ||||||
| 09/02/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: RESPIRATORY | ||||||
| 08/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Inflammation | ||||||
| 08/14/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Diabetes | ||||||
| 08/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: Obesity | ||||||
| 07/26/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/25/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Diabetes | ||||||
| 07/23/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: VACCINE | ||||||
| 07/08/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.96 | General |
| 06/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Cardio-renal | ||||||
| 06/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 2,204 | 3,496 | $534,391 | $264,301 |
| 2022 | 22 | 2,406 | 3,902 | $600,112 | $287,900 |
| 2021 | 25 | 2,764 | 3,883 | $556,102 | $276,087 |
| 2020 | 14 | 1,359 | 1,434 | $201,338 | $99,335 |
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 3 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 28 | 28 | $10,696 | $2,936 | 27.4% |
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 45 | 46 | $5,152 | $1,545 | 30.0% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 31 | 35 | $2,675 | $1,237 | 46.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 62 | 62 | $2,356 | $987.24 | 41.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 28 | 28 | $2,156 | $928.87 | 43.1% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 81 | 98 | $6,468 | $924.85 | 14.3% |
| 90682 | Vaccine for influenza derived from dna for injection into muscle, quadrivalent, preservative and antibiotic free | Office | 2021 | 14 | 14 | $1,190 | $913.64 | 76.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 12 | 12 | $2,400 | $762.30 | 31.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 62 | 62 | $5,766 | $603.72 | 10.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 13 | 14 | $1,778 | $561.26 | 31.6% |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Office | 2021 | 21 | 21 | $1,533 | $552.40 | 36.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 12 | 48 | $1,968 | $504.78 | 25.6% |
| 87804 | Detection test by immunoassay for influenza virus | Office | 2021 | 11 | 22 | $924.00 | $364.10 | 39.4% |
| 69209 | Removal of impacted ear wax by washing | Office | 2021 | 22 | 22 | $814.00 | $209.57 | 25.7% |
| 81003 | Automated urinalysis test | Office | 2021 | 52 | 64 | $1,984 | $144.00 | 7.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 387 | 425 | $70,125 | $32,860 | 46.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 102 | 103 | $23,175 | $11,226 | 48.4% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 171 | 171 | $12,825 | $10,367 | 80.8% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2020 | 41 | 41 | $15,949 | $9,436 | 59.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 122 | 150 | $17,400 | $8,367 | 48.1% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 55 | 55 | $11,550 | $6,596 | 57.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 35 | 35 | $10,850 | $5,727 | 52.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 42 | 42 | $7,350 | $4,641 | 63.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 29 | 29 | $8,569 | $3,194 | 37.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 186 | 186 | $12,834 | $2,934 | 22.9% |
About Dr. Michael Sperling, M.D
Dr. Michael Sperling, M.D is a Internal Medicine healthcare provider based in Little River, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/22/2017. The National Provider Identifier (NPI) number assigned to this provider is 1326579392.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Sperling, M.D has received a total of $3,142 in payments from pharmaceutical and medical device companies, with $913.52 received in 2024. These payments were reported across 201 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($3,078).
As a Medicare-enrolled provider, Sperling has provided services to 8,733 Medicare beneficiaries, totaling 12,715 services with total Medicare billing of $927,624. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Little River, SC
- Active Since 03/22/2017
- Last Updated 02/24/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1326579392
Products in Payments
- Ozempic (Drug) $247.99
- Vascepa (Drug) $226.58
- Otezla (Drug) $207.00
- QULIPTA (Drug) $202.29
- ELIQUIS (Drug) $199.29
- Wegovy (Drug) $196.31
- VRAYLAR (Drug) $156.32
- XIFAXAN (Drug) $104.77
- UBRELVY (Drug) $94.96
- Rybelsus (Drug) $88.08
- FARXIGA (Drug) $82.24
- Kerendia (Drug) $75.58
- XARELTO (Drug) $73.89
- EVENITY (Biological) $67.52
- Dexcom G6 Transmitter (Medical Supply) $58.26
- GEMTESA (Drug) $54.90
- GVOKE PFS (Drug) $54.03
- ENTRESTO (Drug) $53.96
- AREXVY (Drug) $50.00
- SHINGRIX (Biological) $48.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Little River
Dr. Yuxuan Mao, M.d., M.s, M.D., M.S
Internal Medicine — Payments: $87,660
Marc Comianos, Do, DO
Internal Medicine — Payments: $17,613
Kevin Dineen, Md, MD
Internal Medicine — Payments: $14,769
Dr. Donny Huynh, M.d, M.D
Internal Medicine — Payments: $8,317
Dr. Ruth Wieland, Md, MD
Internal Medicine — Payments: $7,362
Dr. Robert Prinzi, Md, MD
Internal Medicine — Payments: $3,545